Relative roles of HBsAg seroclearance and mortality in the decline of hbsag prevalence with increasing age

American Journal of Gastroenterology

Volumn 105, Issue 5, 2010, Pages 1102-1109

  Tai, Dar In ^a,b   Tsay, Pei Kwei ^b   Chen, Wei Ting ^a   Chu, Chia Ming ^a,b   Liaw, Yun Fan ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; PREVALENCE; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 77951977458     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.669     Document Type: Article

References (30)

1. Chen DS, Sung JL, Lai MY. A seroepidemiologic study of hepatitis B virus infection in Taiwan. Taiwan Yi Xue Hui Za Zhi 1978; 77: 908-918
2. Sung JL, Chen DS, Lai MY et al. Epidemiological study on hepatitis B virus infection in Taiwan. Chinese J Gastroenterol 1984; 1: 1-9.
3. Lin HH, Huang LC, Lin DY. Hepatitis B virus infection in Eastern Taiwan: Viewed from a regional general hospital. Tz'u-Chi Med J 1992; 4: 94-99
4. Yang HI, Lu SN, Liaw YF et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-174
5. Tsay PK, Tai DI, Chen YM et al. Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Chang Gung Med J 2009; 32: 155-164
6. Blumberg BS, Melartin L, Guint RA et al. Family studies of a human serum isoantigen system (Australia antigen). Am J Hum Genet 1966; 18: 594-608.
7. Koulentaki M, Ergazaki M, Moschandrea J et al. Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a fi ve-year observational study. BMC Public Health 2001; 1: 17.
8. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology 2007; 46: 1034-1040
9. Tai DI, Chen CH, Chang TT et al. Eight-year nation wide survival analysis in relatives of hepatocellular carcinoma: role of viral infection. J Gastroenterol Hepatol 2002; 17: 682-689
10. Hung YT, Lin DY, Chiu CT. Risk factors of hepatocellular carcinoma with familial tendency. Chang Gung Med J 1995; 18: 8-13.
11. Lin HH, Kao JH, Chang TC et al. Secular trend of age-specifi c prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. J Med Virol 2003; 69: 466-470
12. Chen CH, Chen YY, Chen GH et al. Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13,676 relatives with hepatocellular carcinoma. J Hepatol 2004; 40: 653-659
13. Liaw YF, Sheen IS, Chen TJ et al. Incidence, determinants and signifi cance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991; 13: 627-631
14. Chen YC, Sheen IS, Chu CM et al. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002; 123: 1084-1089
15. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 2007; 45: 1187-1192
16. Tai DI, Lin SM, Sheen IS et al. Long-term outcome of HBeAg-negative HBsAg carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 2009; 49: 1859-1867
17. Chen CJ, Yang HI, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
18. Manno M, Camm à C, Schepis F et al. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality aft er 30 years. Gastroenterology 2004; 127: 756-763
19. Tai DI, Changchien CS, Hung CS et al. Replication of hepatitis B virus in fi rst-degree relatives of patients with hepatocellular carcinoma. Am J Trop Med Hyg 1999; 61: 716-719
20. Zacharakis GH, Koskinas J, Kotsiou S et al. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). J Med Virol 2005; 77: 173-179
21. Feld JJ, Ayers M, El-Ashry D et al. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2007; 46: 1057-1070
22. Hsu CS, Liu CJ, Liu CH et al. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int 2008; 28: 271-277
23. Wang CC, Hsu CS, Liu CJ et al. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 2008; 23: 779-782
24. Shi JP, Fan JG, Wu R et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2008; 23: 1419-1425
25. Chu CM, Lin DY, Liaw YF. Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection? Int J Obes (London) 2007; 31: 871-875
26. Lok AS, McMahon BJ. Chronic Hepatitis B:AASLD Practice guidelines. Hepatology 2007; 45: 507-539
27. Liaw YF, Leung N, Kao JH, et al., for the Chronic Hepatitis B Guideline Workshop Party of the Asian-Pacifi c Association for the Study of the Liver. Asian-Pacifi c Consensus statement on the management of chronic hepatitis B: A 2008 update. Hepatol Int 2008; 2: 263-283
28. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-242
29. Liaw YF, Tai DI, Chu CM et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis: A prospective study. Gastroenterology 1986; 90: 263-267
30. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582-592